🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

988 notícias encontradas para "admin"
FDA approves Tzield for children with new stage 3 type 1 diabetes
The U.S. Food and Drug Administration has granted accelerated approval to Sanofi's Tzield (teplizumab-mzwv) to delay the decline in endogenous insulin production in children aged 8 to 17 years recently diagnosed with stage 3 type 1 diabetes.
Repurposed cancer drug rapidly eased rare autoimmune neuropathy in two patients
An interdisciplinary team at Jena University Hospital achieved a surprisingly rapid and significant improvement in two patients with an autoimmune peripheral nervous system disorder. The team administered teclistamab, a drug originally developed for multiple myeloma, and reported
Aid for brain-bleed recovery receives expedited review
A noninvasive neuromodulation technology has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for reducing a dangerous narrowing of blood vessels in the brain that can follow a brain bleed from a ruptured aneurysm.
FDA approves first treatment for thyroid eye disease
The U.S. Food and Drug Administration has approved Lumvoa (veligrotug-vvze) for the treatment of thyroid eye disease (TED). Approval was granted to Viridian Therapeutics.
Heroin-assisted treatment improves patients' health along with their quality of life
At two clinics in Oslo and Bergen, a small group of patients have been given a new treatment option for opioid addiction. Twice daily, they receive pharmaceutical heroin as medication, administered under close supervision and monitoring by health personnel.
Gene clues reveal why some rare leukemia patients resist tagraxofusp therapy
Researchers at The University of Texas MD Anderson Cancer Center have identified why some patients with a rare type of leukemia, called blastic plasmacytoid dendritic cell neoplasm (BPDCN), eventually develop resistance to tagraxofusp, the first Food and Drug Administration-appro
FDA expands use of first sickle cell disease gene therapy for children as young as 2 years
The U.S. Food and Drug Administration has issued a supplemental approval for Casgevy (exagamglogene autotemcel) for patients ages 2 and older with either sickle cell disease (SCD) with recurrent vaso-occlusive crises (VOCs) or transfusion-dependent β thalassemia (TDT). Supplement
A call for greater focus on social factors that shape health
A call for greater focus on social factors that shape health
The American College of Sports Medicine (ACSM) has published a new call to action statement urging the sports medicine community to intentionally incorporate social determinants of health (SDoH) into research, clinical care, and administrative and organizational decision-making t
Research confirms safety in voluntary assisted dying
Research confirms safety in voluntary assisted dying
New research demonstrates that the Victorian model for oral self-administration of voluntary assisted dying (VAD) medication is safe and effective, providing the largest global experience of patient outcomes.
US: Trump threatens prison for Reflecting Pool 'vandalism'
US: Trump threatens prison for Reflecting Pool 'vandalism'
The Trump administration spent $14.7 million repainting the pool "American flag blue" ahead of US' 250th anniversary celebrations. Weeks later, the paint is peeling off and algae has turned the water green.
Foto: Markus Spiske / Pexels
Experts fired by Trump resurrect mothballed climate website
Fired US federal workers have revived a defunct climate website — pushing back as the Trump administration escalates cuts to publicly funded science and research.
US declines to renew USMCA trade pact with Mexico, Canada
Lengthy negotiations are expected as the Trump administration seeks changes to a trade deal with Mexico and Canada that has streamlined supply chains across North America.